Why the study?
AF is a common adverse outcome in patients with T2D, but the role of genetics in identifying those at risk of AF within this high-risk group had not been comprehensively studied.
Population
20,009 individuals from two prospective cohorts of Chinese patients with T2D
Comparison
97-variant AF polygenic risk score plus CHARGE-AF score vs CHARGE-AF score alone, and across polygenic risk score quintiles
Design
Analysis of two prospective cohorts
Answers are grounded in this paper and cite their sources.
May aid AF risk stratification in T2D; leaves open clinical utility pending validation trials.
Background Atrial fibrillation (AF) is a common adverse outcome in patients with type 2 diabetes (T2D); however, the role of genetics in identifying those at risk of AF within this high-risk group have not been comprehensively studied. Methods A total of 20,009 individuals from two prospective cohorts of Chinese patients with T2D were analyzed. We calculated a polygenic risk score (PRS AF ) comprising 97 variants previously associated with AF risk. Associations of PRS AF with incident AF and other cardiovascular endpoints were assessed using Cox regression, adjusted for baseline covariates. We also determined whether adding PRS AF improved prediction compared to the CHARGE-AF score using C-index, net reclassification improvement index, and integrated discrimination improvement index. Results Incident AF occurred in 986 patients (5.1%) across the two cohorts. A higher PRS AF , adjusted for sex, age, duration of diabetes, and principal components, was associated with increased risks of incident AF (HR [95% CI] per SD = 1.42 [1.33–1.51]), stroke (1.07 [1.01–1.12]), and congestive heart failure (1.10 [1.04–1.17]). These associations remained significant in the fully adjusted model. Patients in the top PRS AF quintile were over 2.5-fold (95% CI = 2.08–3.17) as likely to develop AF than those in the bottom quintile. A novel risk score that integrates the PRS AF into the CHARGE-AF score significantly improved both discrimination and reclassification compared to the CHARGE-AF score alone. Conclusions In patients with T2D, PRS AF is an independent risk factor for AF, providing incremental value in prediction and risk stratification, beyond that achieved with a validated clinical risk score.
No takes yet. Share an insight, caveat, or question.
Tam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: